Ainos, Inc. (NASDAQ:AIMD) Short Interest Update

Ainos, Inc. (NASDAQ:AIMD) saw a significant decrease in short interest in the month of September. As of September 15th, there was short interest totalling 122,800 shares, a decrease of 27.9% from the August 31st total of 170,400 shares. Based on an average daily volume of 521,300 shares, the short-interest ratio is presently 0.2 days. Approximately 8.4% of the shares of the company are sold short.

Ainos Trading Down 5.4 %

NASDAQ:AIMD opened at $0.50 on Friday. The company has a quick ratio of 1.45, a current ratio of 1.48 and a debt-to-equity ratio of 0.43. The company has a 50 day simple moving average of $0.60 and a two-hundred day simple moving average of $0.86. Ainos has a 12 month low of $0.45 and a 12 month high of $4.29.

Ainos (NASDAQ:AIMD) last issued its quarterly earnings data on Monday, August 5th. The company reported ($0.49) EPS for the quarter. Ainos had a negative return on equity of 64.54% and a negative net margin of 15,348.14%.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.